ESC Premium Access

Clinical impact of immediate residual stenosis on clinical outcomes after deploying everolimus-eluting stent and biolimus-eluting stents: insights from a pooled analysis of RESET and NEXT trial.

Congress Presentation

About the speaker

Mr Hiroki Watanabe

Japan Red Cross Society Wakayama Medical Center, Wakayama (Japan)
1 presentation
0 follower

11 more presentations in this session

Impact of the J-CTO score on long-term target lesion revascularization rate after native chronic total coronary occlusion angioplasty

Speaker: Doctor M. Abe (Kyoto, JP)

Thumbnail

Contribution of post-stent irregular protrusion to in-stent neoatheroscrelosis after second-generation drug-eluting stent implantation. - Optical coherence tomography study-

Speaker: Doctor Y. Sanuki (Kitakyusyu, JP)

Thumbnail

Impact of chronic kidney disease on stent strut coverage and neointimal tissue characteristics as assessed by optical coherence tomography

Speaker: Miss Y. Wang (Harbin, CN)

Thumbnail

Predictors of target lesion revascularization after paclitaxel-coated balloon treatment of in-stent restenosis: a real-world single center registry.

Speaker: Doctor I. Bossi (Milano, IT)

Thumbnail

Five-year outcomes after first- or second-generation drug-eluting stent implantation in all-comer patients undergoing percutaneous coronary intervention

Speaker: Doctor H. Yano (Odawara, JP)

Thumbnail

Access the full session

Poster session 1 - PCI - Restenosis

Speakers: Mr H. Watanabe, Doctor M. Abe, Doctor Y. Sanuki, Miss Y. Wang, Doctor I. Bossi...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb